Eletriptan how supplied storage and handling: Difference between revisions

Jump to navigation Jump to search
mNo edit summary
mNo edit summary
 
Line 13: Line 13:
| [[File:Ele06.png|800px|thumb]]
| [[File:Ele06.png|800px|thumb]]
|}
|}
Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].


==References==
==References==

Latest revision as of 07:58, 10 February 2014

Eletriptan
RELPAX® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Eletriptan
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

How Supplied/Storage and Handling

RELPAX Tablets containing 20 mg or 40 mg eletriptan (base) as the hydrobromide salt. RELPAX Tablets are orange, round, convex shaped, film-coated tablets with appropriate debossing. They are supplied in the following strengths and package configurations:[1]

Relpax Tablets

File:Ele06.png

Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].

References

  1. "RELPAX (ELETRIPTAN HYDROBROMIDE) TABLET, FILM COATED [ROERIG]".

Adapted from the FDA Package Insert.